Logo image of XRAY

DENTSPLY SIRONA INC (XRAY) Stock Analyst Earnings Estimates

NASDAQ:XRAY - Nasdaq - US24906P1093 - Common Stock - Currency: USD

19.44  +0.08 (+0.41%)

After market: 19.44 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
XRAY revenue by date.XRAY revenue by date.
4.231B
26.71%
3.922B
-7.30%
3.965B
1.10%
3.885B
-2.02%
3.812B
-1.88%
3.928B
3.04%
4.167B
6.08%
4.377B
5.04%
EBITDA
YoY % growth
XRAY ebitda by date.XRAY ebitda by date.
974M
59.41%
692M
-28.95%
639M
-7.66%
674.71M
5.59%
691.3M
2.46%
749.22M
8.38%
820.08M
9.46%
901.68M
9.95%
EBIT
YoY % growth
XRAY ebit by date.XRAY ebit by date.
628M
126.71%
364M
-42.04%
296M
-18.68%
468.02M
58.11%
527.56M
12.72%
591.9M
12.20%
608.84M
2.86%
854.76M
40.39%
Operating Margin
XRAY operating margin by date.XRAY operating margin by date.
14.84%9.28%7.47%12.05%13.84%15.07%14.61%19.53%
EPS
YoY % growth
XRAY eps by date.XRAY eps by date.
2.87
60.34%
2.08
-27.53%
1.83
-12.02%
1.87
2.38%
1.97
4.99%
2.26
14.72%
2.67
18.12%
3.35
25.51%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.45
2.42%
0.43
2.81%
0.51
3.62%
0.50
0.64%
0.54
18.93%
0.49
14.57%
0.60
18.53%
0.58
15.54%
0.59
10.38%
Revenue
Q2Q % growth
941.14M
-7.00%
936.58M
-1.72%
985.01M
0.10%
944.18M
-0.72%
960.62M
2.07%
954.92M
1.96%
1.013B
2.84%
974.51M
3.21%
1.01B
5.14%
EBITDA
Q2Q % growth
161.22M
-61.06%
158.67M
14.98%
179.5M
-26.73%
179.79M
-45.19%
185.78M
15.23%
175.44M
10.57%
196.86M
9.67%
184.62M
2.69%
196.86M
5.96%
EBIT
Q2Q % growth
127.14M
79.07%
123.01M
136.56%
142.31M
94.95%
140.22M
109.28%
149.5M
17.59%
143.82M
16.92%
165.24M
16.11%
153M
9.11%
165.24M
10.53%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
0.50
2.04%
0.480.024.59%
Q2 2024
Q2Q % growth
0.49
-3.92%
0.51-0.02-3.31%
Q1 2024
Q2Q % growth
0.42
7.69%
0.43-0.01-1.58%
Q4 2023
Q2Q % growth
0.44
-4.35%
0.440.00-0.45%
Q3 2023
Q2Q % growth
0.49
19.51%
0.490.00-0.67%
Q2 2023
Q2Q % growth
0.51
-26.09%
0.440.0716.28%
Q1 2023
Q2Q % growth
0.39
-25.00%
0.350.0412.73%
Q4 2022
Q2Q % growth
0.46
-39.47%
0.330.1340.20%
Q3 2022
Q2Q % growth
0.41
-39.71%
0.58-0.17-29.60%
Q2 2022
Q2Q % growth
0.69
-2.82%
0.570.1220.02%
Q1 2022
Q2Q % growth
0.52
-27.78%
0.57-0.05-8.36%
Q4 2021
Q2Q % growth
0.76
-12.64%
0.80-0.04-5.30%
Q3 2021
Q2Q % growth
0.68
1.49%
0.660.022.42%
Q2 2021
Q2Q % growth
0.71
494.44%
0.660.057.14%
Q1 2021
Q2Q % growth
0.72
67.44%
0.570.1525.70%
Q4 2020
Q2Q % growth
0.87
19.18%
0.650.2233.11%
Q3 2020
Q2Q % growth
0.67
17.54%
0.320.35106.78%
Q2 2020
Q2Q % growth
-0.18
-127.27%
-0.02-0.16-629.22%
Q1 2020
Q2Q % growth
0.43
-12.24%
0.390.049.42%
Q4 2019
Q2Q % growth
0.73 0.76-0.03-4.14%
Q3 2019
Q2Q % growth
0.57 0.510.0610.95%
Q2 2019
Q2Q % growth
0.66 0.640.023.23%
Q1 2019
Q2Q % growth
0.49 0.400.0923.72%
XRAY Yearly EPS VS EstimatesXRAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
951M
0.42%
957.88M-6.88M-0.72%
Q2 2024
Q2Q % growth
984M
-4.28%
1.015B-31M-3.05%
Q1 2024
Q2Q % growth
953M
-2.56%
988.52M-35.52M-3.59%
Q4 2023
Q2Q % growth
1.012B
2.95%
996.4M15.6M1.57%
Q3 2023
Q2Q % growth
947M 994.71M-47.71M-4.80%
Q2 2023
Q2Q % growth
1.028B
0.49%
1.019B9M0.88%
Q1 2023
Q2Q % growth
978M
0.93%
956.45M21.55M2.25%
Q4 2022
Q2Q % growth
983M
-7.96%
960.19M22.81M2.38%
Q3 2022
Q2Q % growth
947M
-8.94%
1.047B-100M-9.55%
Q2 2022
Q2Q % growth
1.023B
-3.67%
1.032B-9M-0.87%
Q1 2022
Q2Q % growth
969M
-5.56%
1.008B-39M-3.87%
Q4 2021
Q2Q % growth
1.068B
-1.05%
1.152B-84M-7.29%
Q3 2021
Q2Q % growth
1.04B
16.23%
1.046B-6M-0.57%
Q2 2021
Q2Q % growth
1.062B
116.47%
1.033B29M2.81%
Q1 2021
Q2Q % growth
1.026B
17.35%
967.68M58.32M6.03%
Q4 2020
Q2Q % growth
1.079B
-2.26%
1.016B63.3M6.23%
Q3 2020
Q2Q % growth
894.8M
-7.00%
855.8M39M4.56%
Q2 2020
Q2Q % growth
490.6M
-51.40%
502.4M-11.8M-2.35%
Q1 2020
Q2Q % growth
874.3M
-7.60%
891.03M-16.73M-1.88%
Q4 2019
Q2Q % growth
1.104B 1.11B-5.7M-0.51%
Q3 2019
Q2Q % growth
962.1M 961.46M640K0.07%
Q2 2019
Q2Q % growth
1.009B 1.059B-49.6M-4.68%
Q1 2019
Q2Q % growth
946.2M 943.57M2.63M0.28%
XRAY Yearly Revenue VS EstimatesXRAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -25.21% 0% -7.21%
Revenue0% -10.28% -0.03% -1.84%